Comparing Clean Intermittent Self-catheterization and Indwelling Catheterization for the Management of Urinary Retention Before BPH Surgery.

计划入组 106 人 · 首次发布于 2026 年 4 月 29 日

A Phase 1 Trial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic Cancer

计划入组 13 人 · 首次发布于 2013 年 12 月 19 日

Clinical Evaluation Of The PARADYM RF Device

计划入组 75 人 · 首次发布于 2010 年 9 月 2 日

IDC-009

IDC-006

IDC-008

Ndc Inc

United States

BIOGEN IDEC INC.

United States

Biogen Idec Inc

United States

Hovione and IDC Launch Commercial Intranasal Drug Delivery Platform with Single-Use Dry Powder Device

MindHYVE.ai Partners with Islamabad Diagnostic Centre to Deploy AGI-Powered Diagnostic Intelligence Across Pakistan

Prestige Biopharma Files Patent for Novel Subcutaneous Antibody Delivery Platform IDC224